Clinical Trials Browser

Phase 2 × Terminated × Castration-Resistant Prostate Carcinoma × Clear all

NCT04951492 2025-01-01

Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma

Phase 2 Terminated

2 enrolled 9 charts

Castration-Resistant Prostate Carcinoma